BOSTON — Beacon Hill lawmakers have unveiled a bill designed to tighten regulations on the state’s compounding pharmacies.
The Committee on Public Health approved a bill Tuesday that supporters say will modernize oversight by mandating unannounced inspections of compounding pharmacies and requiring them to report their drug production by type and volume.
The bill also incorporates a proposal by Gov. Deval Patrick to create specialty licenses for all in-state and out-of-state sterile compounding pharmacies.
The industry has come under scrutiny after a fungal meningitis outbreak traced to tainted steroids produced at the now-shuttered New England Compounding Pharmacy in Framingham killed 61 people and sickened more than 749 others.
The bill is also intended to improve communication between prescribers, pharmacies, regulators, and the public.
The bill now heads to the full House and Senate.
quoted from here
No comments:
Post a Comment